Welcome to CDC Stacks | Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae. - 15031 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
  • Published Date:
    2000 Sep-Oct
  • Source:
    Emerg Infect Dis. 6(5):552-556.
Filetype[PDF - 33.12 KB]


Details:
No Related Documents.
You May Also Like:
  1. Antimicrobial Resistance in Streptococcus pneumoniae, Taiwan
    Personal Author:
    Hsueh, Po-Ren; Luh, Kwen-Tay;
    Published:
    Dec 2002
    Source:
    Emerg Infect Dis. 8(12):1487-1491.
    Description:
    Taiwan has one of the highest levels of antibiotic-resistant pneumococcus in the world. Pneumococcal isolates not susceptible to penicillin first appeared in Taiwan in 1986; in 1995 an increase in the prevalence of nonsusceptibility to penicillins, e...
    File Type:
    Filetype[PDF - 214.90 KB]
  2. Antimicrobial Drug Use and Resistance in Europe
    Personal Author:
    van de Sande-Bruinsma, Nienke; Grundmann, Hajo; Verloo, Didier; Tiemersma, Edine; Monen, Jos; Goossens, Herman; Ferech, Matus;
    Corporate Author:
    European Antimicrobial Resistance Surveillance System and European Surveillance of Antimicrobial Consumption Project Groups
    Published:
    Nov 2008
    Source:
    Emerg Infect Dis. 14(11):1722-1730.
    Description:
    Our study confronts the use of antimicrobial agents in ambulatory care with the resistance trends of 2 major pathogens, Streptococcus pneumoniae and Escherichia coli, in 21 European countries in 2000-2005 and explores whether the notion that antimicr...
    File Type:
    Filetype[PDF - 206.81 KB]
  3. Serotype Distribution and Drug Resistance in Streptococcus pneumoniae, Palestinian Territories
    Personal Author:
    Kattan, Randa; Abu Rayyan, Amal; Zheiman, Inas; Idkeidek, Suzan; Baraghithi, Sabri; Rishmawi, Nabeel; Turkuman, Sultan; Abu-Diab, Afaf; Ghneim, Riyad; Zoughbi, Madeleine; Dauodi, Rula; Ghneim, Raed; Issa, Abed-El-Razeq; Siryani, Issa; Al Qas, Randa; Liddawi, Rawan; Khamash, Hatem; Kanaan, Moein; Marzouqa, Hiyam; Hindiyeh, Musa Y.;
    Published:
    Jan 2011
    Source:
    Emerg Infect Dis. 17(1):94-96.
    Description:
    To determine antimicrobial drug resistance of Streptococcus pneumoniae serotypes, we analyzed isolates from blood cultures of sick children residing in the West Bank before initiation of pneumococcal vaccination. Of 120 serotypes isolated, 50.8%, 73....
    File Type:
    Filetype[PDF - 237.72 KB]
  4. Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance
    Personal Author:
    Lim, Sue; Bast, Darrin; McGeer, Allison; de Azavedo, Joyce; Low, Donald E.;
    Published:
    Jul 2003
    Source:
    Emerg Infect Dis. 9(7):833-837.
    Description:
    Clinical antimicrobial susceptibility breakpoints are used to predict the clinical outcome of antimicrobial treatment. In contrast, microbiologic breakpoints are used to identify isolates that may be categorized as susceptible when applying clinical ...
    File Type:
    Filetype[PDF - 258.72 KB]
  5. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
    Personal Author:
    Doern, G. V.; Brueggemann, A. B.; Huynh, H.; Wingert, E.;
    Published:
    1999 Nov-Dec
    Source:
    Emerg Infect Dis. 5(6):757-765.
    Description:
    From November 1997 to April 1998, 1,601 clinical isolates of Streptococcus pneumoniae were obtained from 34 U.S. medical centers. The overall rate of strains showing resistance to penicillin was 29. 5%, with 17.4% having intermediate resistance. Mult...
    File Type:
    Filetype[PDF - 92.07 KB]